Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
A single eye just became ground zero for one of science's biggest bets on turning back the clock on aging. Boston-based Life ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results